Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
16568 | 582 | 43.9 | 89% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COFFIN LOWRY SYNDROME | Author keyword | 80 | 84% | 7% | 43 |
2 | RSK2 | Author keyword | 27 | 66% | 4% | 25 |
3 | SL0101 | Author keyword | 23 | 100% | 2% | 10 |
4 | COFFIN LOWRY | Author keyword | 9 | 83% | 1% | 5 |
5 | HISTONE PHOSPHORYLATION | Author keyword | 8 | 33% | 3% | 20 |
6 | MSK1 | Author keyword | 6 | 32% | 3% | 15 |
7 | BI D1870 | Author keyword | 6 | 100% | 1% | 4 |
8 | RSK2 GENE | Author keyword | 6 | 100% | 1% | 4 |
9 | H3 PHOSPHORYLATION | Author keyword | 5 | 54% | 1% | 7 |
10 | P90 RIBOSOMAL S6 KINASE RSK | Author keyword | 5 | 63% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COFFIN LOWRY SYNDROME | 80 | 84% | 7% | 43 | Search COFFIN+LOWRY+SYNDROME | Search COFFIN+LOWRY+SYNDROME |
2 | RSK2 | 27 | 66% | 4% | 25 | Search RSK2 | Search RSK2 |
3 | SL0101 | 23 | 100% | 2% | 10 | Search SL0101 | Search SL0101 |
4 | COFFIN LOWRY | 9 | 83% | 1% | 5 | Search COFFIN+LOWRY | Search COFFIN+LOWRY |
5 | HISTONE PHOSPHORYLATION | 8 | 33% | 3% | 20 | Search HISTONE+PHOSPHORYLATION | Search HISTONE+PHOSPHORYLATION |
6 | MSK1 | 6 | 32% | 3% | 15 | Search MSK1 | Search MSK1 |
7 | BI D1870 | 6 | 100% | 1% | 4 | Search BI+D1870 | Search BI+D1870 |
8 | RSK2 GENE | 6 | 100% | 1% | 4 | Search RSK2+GENE | Search RSK2+GENE |
9 | H3 PHOSPHORYLATION | 5 | 54% | 1% | 7 | Search H3+PHOSPHORYLATION | Search H3+PHOSPHORYLATION |
10 | P90 RIBOSOMAL S6 KINASE RSK | 5 | 63% | 1% | 5 | Search P90+RIBOSOMAL+S6+KINASE+RSK | Search P90+RIBOSOMAL+S6+KINASE+RSK |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SER 10 PHOSPHORYLATION | 25 | 75% | 3% | 18 |
2 | RIBOSOMAL S6 KINASE | 25 | 23% | 16% | 94 |
3 | COFFIN LOWRY SYNDROME | 18 | 33% | 8% | 45 |
4 | RSK2 | 17 | 79% | 2% | 11 |
5 | RSK2 GENE | 13 | 69% | 2% | 11 |
6 | MSK1 | 13 | 44% | 4% | 22 |
7 | EARLY GENE INDUCTION | 12 | 39% | 4% | 25 |
8 | MITOTIC CHROMOSOME CONDENSATION | 11 | 21% | 8% | 46 |
9 | H3 PHOSPHORYLATION | 11 | 27% | 6% | 35 |
10 | PP90RSK | 10 | 50% | 2% | 14 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The RSK family of kinases: emerging roles in cellular signalling | 2008 | 270 | 119 | 44% |
Regulation and function of the RSK family of protein kinases | 2012 | 86 | 181 | 38% |
Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases | 2011 | 346 | 427 | 20% |
The p90 RSK Family Members: Common Functions and Isoform Specificity | 2013 | 9 | 50 | 54% |
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions | 2004 | 1090 | 241 | 21% |
Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation | 2004 | 335 | 48 | 50% |
Coffin-Lowry syndrome: clinical and molecular features | 2002 | 80 | 54 | 72% |
RSK Isoforms in Cancer Cell Invasion and Metastasis | 2013 | 9 | 27 | 41% |
The versatile role of MSKs in transcriptional regulation | 2009 | 64 | 74 | 41% |
The RSK factors of activating the Ras/MAPK signaling cascade | 2008 | 76 | 133 | 42% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PARTNERS DRUG DISCOVERY | 3 | 57% | 0.7% | 4 |
2 | EQUIPE MECANISMES ASSEMBLAGE MAT GENET | 2 | 67% | 0.3% | 2 |
3 | MED DIAGNOST GUANGDONG PROV | 1 | 100% | 0.3% | 2 |
4 | BONE DIS PROGRAM | 1 | 50% | 0.2% | 1 |
5 | CHROMOSOME STRUCT FUNCT GRP | 1 | 50% | 0.2% | 1 |
6 | CLIN DISABLED | 1 | 50% | 0.2% | 1 |
7 | COLOR ULTRASON ROOM | 1 | 50% | 0.2% | 1 |
8 | KINASE SIGNALLING | 1 | 50% | 0.2% | 1 |
9 | MB CELL BIOL | 1 | 50% | 0.2% | 1 |
10 | NEURAL REGENERAT REPAIRING | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000170960 | VRK1//VRK2//EXPT THER EUT TRANSLAT ONCOL PROGRAM |
2 | 0.0000099199 | S6K2//S6 KINASE//RIBOSOMAL S6 KINASE 2 S6K2 |
3 | 0.0000098459 | KSR1//PEA 15//IST ENDOCRINOL ONCOL SPERIMENTALE GAETANO SALVA |
4 | 0.0000078394 | CREM//CREB//SALT INDUCIBLE KINASE |
5 | 0.0000075814 | AURORA A//AURORA KINASES//AURORA KINASE |
6 | 0.0000072610 | HISTONE DEMETHYLASE//HISTONE DEMETHYLATION//LSD1 |
7 | 0.0000070183 | MK2//MAPKAP K2//MK5 |
8 | 0.0000068600 | CYTOSTATIC FACTOR//MOS ONCOGENE//MPF |
9 | 0.0000067527 | CYTOTOXIC CYTOSTATIC EFFECT//TALOSIN A//6 DEOXY TALOSE |
10 | 0.0000066609 | X LINKED MENTAL RETARDATION//XLMR//PQBP1 |